Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Grastek

    - PMLiVE

    David Weinreich appointed as Merck’s Global Head of R&D and CMO, Healthcare

    Weinreich will be based in Billerica, Massachusetts at the company’s Research and Development site

    - PMLiVE

    MSD’s Welireg recommended by NICE to treat rare von Hippel-Lindau disease

    Approximately one in every 70,000 people are affected by the tumour-causing genetic disease

    - PMLiVE

    Merck and Daiichi Sankyo to jointly develop T-cell engager in deal worth over $170m

    The partners will evaluate MK-6070 as part of a combination treatment for small cell lung cancer

    - PMLiVE

    Merck and Astellas/Pfizer’s bladder cancer combination receives positive CHMP opinion

    More than 165,000 new cases of bladder cancer are diagnosed in the EU every year

    - PMLiVE

    Merck’s Keytruda combination recommended by NICE for advanced gastric cancer

    More than 6,500 new cases of gastric cancer are diagnosed in the UK every year

    - PMLiVE

    Merck’s investigational RSV monoclonal antibody clesrovimab shown to protect infants

    The respiratory virus accounts for about 30,000 hospitalisations in children under five every year in the UK

    - PMLiVE

    ICR study reveals Lynparza could treat more advanced prostate cancer patients

    Up to 30% of men living with the advanced disease have tumours that contain defects in repairing DNA

    - PMLiVE

    Merck’s pulmonary arterial hypertension therapy receives CHMP recommendation

    Approximately 30,000 people in the EU are currently living with the rare blood disorder

    - PMLiVE

    Merck’s adult-specific pneumococcal vaccine Capvaxive granted FDA approval

    The vaccine is designed to protect against the strains responsible for the majority of adult invasive pneumococcal disease

    - PMLiVE

    Merck to expand ophthalmology pipeline with acquisition of EyeBio in deal worth up to $3bn

    Merck will gain access to EyeBio’s Restoret to prevent and treat retinal vascular leakage-associated vision loss

    - PMLiVE

    Merck presents positive results for Keytruda plus chemotherapy in breast cancer

    Triple-negative breast cancer accounts for 24% of all newly diagnosed cancers worldwide

    - PMLiVE

    Merck’s adult-specific pneumococcal vaccine shows promise in late-stage study

    There are more than 100 types of pneumococcal bacteria, which can affect adults differently than children

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links